Press Releases
15 September 2018
BioCardia®, Inc., a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the issuance of two United States
Read more...14 September 2018
Acelity today announced an agreement to sell its Advanced Dressing Facility located in Gargrave, England, to Scapa Healthcare. In addition to the transfer of the facility following the closing of t
Read more...14 September 2018
EarlySense, the market leader in contact-free continuous monitoring solutions across the care continuum, announced today a comprehensive implementation by Franciscus Gasthuis & Vlietland (Rotte
Read more...12 September 2018
The transportation industry will have more and easier access to a game-changing soft-tissue injury management program, thanks to a newly announced partnership. CasKen,
Read more...InterSystems, a global leader in health information technology, today announced that the InterSystems TrakCare® unified healthcare information system has added a mobile, touchscreen-enabled use
Read more...11 September 2018
Genesys Spine is pleased to announce the FDA clearance of our latest product line, the AIS-C Stand-Alone System. The AIS-C Stand-Alone system is a first of its kind, non-screw based, zero
Read more...11 September 2018
Minnetronix, Inc., a leading medical technology and solutions provider, today announced that it has rebranded as Minnetronix Medical, Inc. The rebrand reflects the company’s continued investm
Read more...CogniFit, a world leader in neuropsychological testing, brain training, and cognitive stimulation, has launched an online cognitive assessment battery designed to help
Read more...7 September 2018
Northwestern Memorial Hospital has been selected as a preferred provider of exceptional medical care for patients from the United Arab Emirates (UAE.) Northwestern Medicine joins a select network o
Read more...7 September 2018
Quantum Leap Healthcare Collaborative™ (QLHC) announced today that a new randomized, investigational treatment arm for the I-SPY 2 TRIAL™ includes the study of olaparib and durvalumab,
Read more...